Scrip Awards: Antidote Named as Finalist in Technology and Partnerships Categories

We’ve long followed the Scrip Awards - where the industry’s highest achievers are recognized for outstanding work across the drug development spectrum. And now, we’re thrilled to announce that Antidote has been named a Scrip Awards finalist in two different categories: “Best Technological Development in Clinical Trials,” for our product Antidote Match, and “Community Partnership of the Year” for our work with JDRF. What an honor to be nominated in two categories that so perfectly align with our mission: to transform the way patients connect with research.

Antidote Match is our trial matching engine that uses structured eligibility criteria, proprietary algorithms, and machine learning to explore a patient’s eligibility for every trial. We power the trial search on more than 200 patient communities and health portals, reaching more than 15 million patients per month. This includes JDRF, through which more than 25,000 patients and loved ones have searched for type 1 diabetes trials. We created this video with JDRF to capture the spirit of diabetes research, and drive interest in taking part:

Our business model combines technology with community in a way that drives awareness of, engagement with, and participation in clinical trials. This means that if you’re looking for patients for your trials, we can help. Get in touch today.